NewsRoom Articles - Page 523 of 587

WednesdayJun 27, 2018 9:00 am

Farm Bill Legislation May Springboard Federal Hemp Acceptance

CannabisNewsWire Editorial Coverage: The United States House passed the 2018 Farm Bill, which will redefine subsidies to farmers, nutritional welfare recipients, conservationists and others. Tucked into this bill of more than 1,000 pages is hemp legalization legislation supported by Senate Majority Leader Mitch McConnell. Demand – and thus farming revenue – for tobacco is waning, and McConnell says hemp farming could help bolster farming communities in his home state of Kentucky and across the country. Currently listed as a controlled substance under federal law, the new bill will declassify hemp as a schedule 1 drug and label it as a…

TuesdayJun 26, 2018 12:12 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Pursuing Diverse Applications for DehydraTECH™ Licensing

Lexaria will license in any of the 40 countries where its technology already has a patent or is patent-pending Company sees up to 80 percent of its future revenues coming from licensing DehydraTECH proprietary ingestion delivery technology DehydraTECH™ has applications for processed foods, tobacco industry, pharmaceutical companies, NSAIDs, supplements and beverages Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has a wide variety of licensing applications for its patented DehydraTECH™ delivery technology. It is already licensed to Nuka Enterprises LLC, maker of “1906” brand cannabis chocolates (http://cnw.fm/HD4bm). Chris Bunka, CEO, emphasizes that his company’s technology applies to far more than just the…

TuesdayJun 26, 2018 11:37 am

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Focusing On Innovative Drug Delivery Technologies

Pivot offers unique proprietary drug delivery platform technologies Company has a strong intellectual property (IP) portfolio for the formulation and delivery of cannabinoids Company acquires licensing rights to patented Trivair™ nasal and pulmonary drug delivery system, also signs exclusive manufacturing agreement with Bio V Pharma Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is a biopharmaceutical company based in Vancouver, British Columbia. Pivot engages in the development and commercialization of premium cannabinoid-based nutraceuticals and pharmaceuticals. It does so utilizing unique drug delivery platform technologies. Pivot Pharmaceuticals’ wholly-owned medical cannabis products division is Pivot Green Stream Health Solutions Inc. (“PGS”).…

MondayJun 25, 2018 2:01 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Rolling Forward with Cannabis Production Facility

Facility in Costa Mesa, California, will enable full range of cannabis distribution services Powdered cannabis CBD and THC formulations for beverage alternatives expected to drive multi-billion-dollar market Pivot Pharmaceuticals expects to have licensing to begin manufacturing by July, with equipment installed by August Cannabis-friendly biopharmaceutical firm Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is rolling at a good pace with its recent announcement that its Canada-based operation has also found solid footing in the United States through a lease agreement on a California manufacturing facility that will allow the company to operate wholesale medical marijuana distribution, manufacture, processing…

MondayJun 25, 2018 1:02 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Debilitating Disorders with Novel CBD-based Drug Delivery Platform

Direct health care treatment for chronic health conditions totaled $1.1 trillion in 2016 Total economic impact of $3.7 trillion in health care costs for chronic diseases in U.S. equivalent to nearly 20 percent of the U.S. gross domestic product Medical research into CBD-based therapies to treat epilepsy and other neuropsychiatric disorders holds great promise for affected individuals Development of CBD-based drug delivery platform that’s able to cross blood brain barrier via nasal route Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is developing innovative options for preventive and curative therapies using some of nature’s most compelling…

MondayJun 25, 2018 12:19 pm

Koios Beverage Corp. (CSE: KBEV) is “One to Watch”

Growing worldwide market for nootropics as a safe way for people to boost brain function and earn a competitive edge Non-prescription cognitive enhancers officially became a billion-dollar industry in 2015 Koios, via its GMP-certified and FDA-compliant lab, has developed nootropic products that are made only with high-quality, natural ingredients and are available prescription-free Koios is available in stores and online and is distributed worldwide Koios Beverage Corp. (CSE: KBEV) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of…

FridayJun 22, 2018 1:40 pm

EVIO Inc. (EVIO) Appoints New Board Member, Aims to Strengthen Biosciences Division

New appointment expected to strengthen EVIO’s Biosciences division Licensed cannabis sales expected to reach $21 billion by 2021 due to industry strengthening and legislative changes U.S. administration signals shift on cannabis legalization, considers leaving leave the decision with each state A leading provider of testing services for the regulated cannabis industry, EVIO Inc. (OTCQB: EVIO) announced the appointment of a new member to its board of directors on June 19, 2018. Felipe Campusano has joined the EVIO board as an independent director. Campusano has extensive experience in operating Canadian pharmacies, which could prove to be invaluable for the EVIO business…

FridayJun 22, 2018 12:54 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Notes Rising Interest in Economic Potential of Industrial Hemp

U.S. legislation to legalize industrial hemp makes significant headway in Congress Non-psychoactive cannabidiol (“CBD”) extracted from industrial hemp expected to become a $1 billion market by 2020 Industrial hemp increasingly seen as an economic boon for farmers seeking alternative agricultural revenue sources Cash Crop Today Investor and Business Resource Summit delivers successful launch during U.S. Hemp History Week Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) has a vision when it comes to industrial hemp – “One world, one plant.” This seemingly simple statement about an ancient plant with so many beneficial uses is ringing true to investors,…

FridayJun 22, 2018 12:18 pm

Medical Cannabis Payment Solutions (REFG) Diversifies Cannabis Industry Commitment with Recent Acquisitions

REFG acquires 40 acres of land in Utah to grow hemp, applies for state license Company also buys SpeedyGrow, which is licensed to grow and process hemp in Colorado REFG’s Green is an integrated gateway that is FinCEN compliant and creates a virtual banking environment for licensed cannabis providers, available for online sign up Company has doubled down on its cannabis activities, both entering the cultivation and extraction space in Utah and offering Green to licensed cannabis merchants/ dispensaries Medical Cannabis Payment Solutions Inc. (OTC: REFG) has diversified its commitment to the cannabis industry, as both a licensed grower and…

FridayJun 22, 2018 11:21 am

BLOCKStrain Technology Corp. (TSX.V: DNAX) Positioned to Benefit from Greater Consumer Spending

Cannabis trends leading to greater consumer spending Cannabis pioneer Derek Pedro joins the BLOCKStrain advisory board Company provides an elegant solution, establishing itself as a major player addressing core issues within the global industry The accelerated pace of legalization in the medical and recreational cannabis industries of North America is leading to a projected increase in consumer spending. By 2027, it is estimated that spending on legal cannabis worldwide will reach $57 billion, with North America projected to dominate the market with an expected growth from 2017’s $9.2 billion to $47.3 billion in 2027. According to Tom Adams, editor-in-chief at…

News and publishing service for cannabis related companies

Contact us: 512.354.7000